Skip to Main Content

Author Details

Shifra Ash
Ruth Rappaport Children's Hospital
1988
87
22
Vardit Ravitsky (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36893946Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation.Crit Rev Oncol Hematol2023
37010353Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.Pediatr Blood Cancer2023
36714934[PEDIATRIC ONCOLOGY, HEMATOLOGY AND BONE MARROW TRANSPLANTATION - PAST PRESENT AND FUTURE FOR PATIENTS].Harefuah2023
36011005Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.Cancers (Basel)2022
35537008New Approaches Promise to Improve Local Ewing Sarcoma Results.J Pediatr Hematol Oncol2022
36299690Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN).Front Pediatr2022
36291829Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study.Cancers (Basel)2022
33205902A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.Pediatr Blood Cancer2021
34152804Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.J Clin Oncol2021
34145514Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic.Int J Clin Oncol2021
34115544Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).J Clin Oncol2021
33316634Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.Eur J Cancer2021
32639845Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.J Clin Oncol2020
32013055Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1).Cancers (Basel)2020
32012928PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies.Molecules2020
32573923Nasopharyngeal carcinoma in children and young adults-Beyond 5-year survival.Pediatr Blood Cancer2020
32710268Novel extra cellular-like matrices to improve human ovarian grafting.J Assist Reprod Genet2020
30570510Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.J Pediatr Hematol Oncol2019
30153089Oncofertility Decision Making: Findings from Israeli Adolescents and Parents.J Adolesc Young Adult Oncol2019
30770960SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS.Cancer Chemother Pharmacol2019
30801444Likelihood of Diagnosing Neuroblastoma in Isolated Horner Syndrome.J Neuroophthalmol2019
29240035Acinic Cell Carcinoma of the Parotid Gland in Children and Adolescents.J Pediatr Hematol Oncol2018
30075974Doxorubicin-Eluting Intra-Arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.J Vasc Interv Radiol2018
30015396Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.Pediatr Blood Cancer2018
30518699Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.JCI Insight2018
30336605Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial.Cancers (Basel)2018
29755120Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.Br J Cancer2018
29374868[LAPAROSCOPICALLY-ASSISTED ULTRASOUND-GUIDED PERCUTANEOUS TRANSABDOMINAL OOCYTE COLLECTION: FERTILITY PRESERVATION IN A 17-YEARS-OLD GIRL WITH VAGINAL EWING SARCOMA].Harefuah2018
29070431Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for disseminated intra-abdominal malignancies in children-a single-institution experience.J Pediatr Surg2018
29243188Current management of lipoblastoma.Eur J Pediatr2018
27677500Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.Clin Rev Allergy Immunol2017
28209418Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.J Pediatr Surg2017
28645442Spinal Canal Involvement in Neuroblastoma.J Pediatr2017
28551906[FERTILITY PRESERVATION IN YOUNG CANCER PATIENTS - CAN WE OPTIMIZE THE PATH?]Harefuah2017
26848188Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.Hum Reprod2016
27506811Optimizing the process of fertility preservation in pediatric female cancer patients - a multidisciplinary program.BMC Cancer2016
27403773Factors Affecting the Upper Limit of the Methotrexate (MTX) CSF Levels Achievable in Children With Brain Tumors Treated With High-dose Intravenous MTX.J Pediatr Hematol Oncol2016
26365289Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).Cancer Chemother Pharmacol2015
26393682The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth.Oncotarget2015
24246763Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.Horm Res Paediatr2014
24777188Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.Bone Marrow Transplant2014
24601987Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.Immunology2014
24566711Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.Bone Marrow Transplant2014
24371009Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.Immunol Res2014
24441107Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells.Pediatr Res2014
23078782Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.Biol Blood Marrow Transplant2013
24223844MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma.PLoS One2013
23612378The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.J Pediatr Hematol Oncol2013
23743300Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease.Exp Hematol2013
23484236Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.Isr Med Assoc J2013
  • 1 - 50 of 87

Recommended Authors

Mayo Clinic
Career Start Year 2009
Number of shared co-authors 1
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 1
University of California los angeles
Career Start Year 2001
Number of shared co-authors 0
St. Christopher's Hospital for Children, Drexel University.
Career Start Year 1999
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 0
Royal Manchester Children's Hospital
Career Start Year 1997
Number of shared co-authors 10
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 3
Centre Leon Berard & Universite Claude Bernard
Career Start Year 1996
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 0
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 3
University Hospital Essen, West German Cancer Center
Career Start Year 1994
Number of shared co-authors 11
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 3
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 0
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 1990
Number of shared co-authors 1
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 1
St Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 1
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 2
Universite Paris-Saclay
Career Start Year 1988
Number of shared co-authors 5
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 0
Clinical Trials Unit
Career Start Year 1983
Number of shared co-authors 4
Boston Children's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 4
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 1
University Hospital Munster
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Children's Cancer Research Institute
Co-authored papers 10
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 6
Institut Curie
Co-authored papers 5
Co-authored papers 2
Co-authored papers 2
AIT Austrian Institute of Technology
Co-authored papers 2
St. Anna Children's Cancer Research Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 1
Institute for Biomedical Ethics, University of Basel
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 1
The Hastings Center
Co-authored papers 1
Institut Curie
Co-authored papers 1
St. Anna Children's Cancer Research Institute
Co-authored papers 1
Co-authored papers 1
Children's Cancer Research Institute
Co-authored papers 1
Hadassah Hebrew University Hospital
Co-authored papers 1
University Children's Hospital of Cologne
Co-authored papers 1
Institute for Biomedical Ethics, University of Basel
Co-authored papers 1
Baylor College of Medicine.
Co-authored papers 1
Institut Curie
Co-authored papers 1
Institut Curie Hospital
Co-authored papers 1